We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

  • Cookie
    cookieyes-consent
  • Duration
    1 year
  • Description

    CookieYes sets this cookie to remember users' consent preferences so that their preferences are respected on subsequent visits to this site. It does not collect or store any personal information about the site visitors.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

  • Cookie
    _dc_gtm_UA-*
  • Duration
    Less than a minute
  • Description

    Google Analytics sets this cookie to load the Google Analytics script tag.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

  • Cookie
    _gcl_au
  • Duration
    3 months
  • Description

    Google Tag Manager sets the cookie to experiment advertisement efficiency of websites using their services.

  • Cookie
    _ga
  • Duration
    1 year 1 month 4 days
  • Description

    Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.

  • Cookie
    _gid
  • Duration
    1 day
  • Description

    Google Analytics sets this cookie to store information on how visitors use a website while also creating an analytics report of the website's performance. Some of the collected data includes the number of visitors, their source, and the pages they visit anonymously.

  • Cookie
    _gat_gtag_UA_*
  • Duration
    Less than a minute
  • Description

    Google Analytics sets this cookie to store a unique user ID.

  • Cookie
    _ga_*
  • Duration
    1 year 1 month 4 days
  • Description

    Google Analytics sets this cookie to store and count page views.

  • Cookie
    _gat_UA-*
  • Duration
    Less than a minute
  • Description

    Google Analytics sets this cookie for user behaviour tracking.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Breakthrough T1D-CIHR Partnership to Defeat Diabetes

The Breakthrough T1D-CIHR Partnership to Defeat Diabetes (formerly JDRF-CIHR) is a landmark collaboration between the Government of Canada, through CIHR, who invested $15M and what was then known as JDRF Canada who matched that investment with an additional $15M to support transformative type 1 diabetes (T1D) research.

In November, 2021 Breakthrough T1D announced a new investment of $7 million to support four Canadian research teams as part of the Partnership to Defeat Diabetes. Four new grants have been funded through this commitment.

This unique partnership ensures that T1D remains a priority in Canadian health research and is based on a shared vision of improved care, treatment, outcomes and cures for those living with T1D.

Since its inception in 2017, this partnership has funded several innovative clinical trials and translational research projects with a view of accelerating the development of novel treatment approaches for people with T1D, in addition to cures for the disease. Multiple new cutting-edge projects will be funded in the coming year, promising to further accelerate Breakthrough T1D’s mission. Learn more about the funded research projects from this partnership.

This is an example of an instrumental partnership that is able to leverage funds from multiple sources and increase the speed at which novel research is conducted – all with one ultimate goal in mind – a world free from type 1 diabetes.